ATOSSA THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $3.1M | $3.0M |
| FY2017 | — | $6.9M | $7.2M |
| FY2018 | — | $8.8M | $10.4M |
| FY2019 | — | $13.2M | $12.6M |
| FY2020 | — | $27.2M | $39.6M |
| FY2021 | — | $138.1M | $136.4M |
| FY2022 | — | $118.0M | $110.9M |
| FY2023 | — | $91.0M | $88.5M |
| FY2024 | — | $71.5M | $71.1M |
| FY2025 | — | $39.4M | $41.3M |